Fenofibrate
- PMID: 30000697
- Bookshelf ID: NBK501636
Fenofibrate
Excerpt
No relevant published information exists on the use of fenofibrate during breastfeeding. Because of a concern with disruption of infant lipid metabolism, fenofibrate is best avoided during breastfeeding. An alternate drug is preferred, especially while nursing a newborn or preterm infant. The manufacturer recommends that breastfeeding be avoided during fenofibrate therapy and for 5 days after the final dose.
Similar articles
-
Comparison table: Some lipid-lowering drugs.Med Lett Drugs Ther. 2022 Sep 19;64(1659):e152-e158. Med Lett Drugs Ther. 2022. PMID: 36094549 No abstract available.
-
Lipid-lowering drugs.Med Lett Drugs Ther. 2019 Feb 11;61(1565):17-24. Med Lett Drugs Ther. 2019. PMID: 30845106 No abstract available.
-
Gemfibrozil.2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000433 Free Books & Documents. Review.
-
Oxaprozin.2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000217 Free Books & Documents. Review.
-
Ethacrynic Acid.2020 Jan 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2020 Jan 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999682 Free Books & Documents. Review.
Publication types
LinkOut - more resources
Full Text Sources